Literature DB >> 35979200

The Neurocognitive Effects of Cannabis Across the Lifespan.

Jarrod M Ellingson1,2, Jesse D Hinckley1, J Megan Ross1,2, Joseph P Schacht1, L Cinnamon Bidwell3,4, Angela D Bryan3,4, Christian J Hopfer1,2, Paula Riggs1, Kent E Hutchison1.   

Abstract

Purpose of review: This review examines the neurocognitive effects of cannabis and relevant developmental factors across adolescence (age 13-21), adulthood (21-65), and older adulthood (65+). Recent findings: Cannabis use is robustly associated with poorer neurocognitive functioning; however, studies that carefully control for confounds have often not found any evidence for impairment. Notably, the endocannabinoid system may underly how cannabis use affects neurocognitive functions, including heightened vulnerability during adolescence. In contrast, the endocannabinoid system may underlie protective neurocognitive effects of cannabis in older adults. Notably, older adults have reported sharp increases in recent cannabis use. Summary: As legalization increases the accessibility, variety, and potency of cannabis, strong empirical evidence is needed to understand its neurocognitive effects across the lifespan. In particular, rigorous study designs are needed to investigate the neurocognitive effects of cannabis, including among vulnerable populations (adolescents, older adults) and mediating (e.g., endocannabinoid system) and moderating factors (e.g., alcohol use).

Entities:  

Keywords:  Cannabinoids; Cannabis; Cognitive; Development; Lifespan; Neurocognitive

Year:  2021        PMID: 35979200      PMCID: PMC9377647          DOI: 10.1007/s40473-021-00244-7

Source DB:  PubMed          Journal:  Curr Behav Neurosci Rep


  88 in total

1.  Acute marijuana effects on rCBF and cognition: a PET study.

Authors:  D S O'Leary; R I Block; M Flaum; S K Schultz; L L Boles Ponto; G L Watkins; R R Hurtig; N C Andreasen; R D Hichwa
Journal:  Neuroreport       Date:  2000-11-27       Impact factor: 1.837

Review 2.  Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.

Authors:  Samantha J Broyd; Hendrika H van Hell; Camilla Beale; Murat Yücel; Nadia Solowij
Journal:  Biol Psychiatry       Date:  2015-12-08       Impact factor: 13.382

Review 3.  Wiring and firing neuronal networks: endocannabinoids take center stage.

Authors:  Tibor Harkany; Ken Mackie; Patrick Doherty
Journal:  Curr Opin Neurobiol       Date:  2008-06       Impact factor: 6.627

4.  Preliminary results from a pilot study examining brain structure in older adult cannabis users and nonusers.

Authors:  Rachel E Thayer; Sophie L YorkWilliams; Kent E Hutchison; Angela D Bryan
Journal:  Psychiatry Res Neuroimaging       Date:  2019-02-10       Impact factor: 2.376

Review 5.  Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.

Authors:  Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri
Journal:  Stroke       Date:  2011-07-21       Impact factor: 7.914

6.  Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease.

Authors:  Mayara Chaves Faria; Gisele Santos Gonçalves; Natália Pessoa Rocha; Edgar Nunes Moraes; Maria Aparecida Bicalho; Marco Túlio Gualberto Cintra; Jonas Jardim de Paula; Luís Felipe José Ravic de Miranda; Alessandro Clayton de Souza Ferreira; Antônio Lúcio Teixeira; Karina Braga Gomes; Maria das Graças Carvalho; Lirlândia P Sousa
Journal:  J Psychiatr Res       Date:  2014-02-13       Impact factor: 4.791

7.  A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.

Authors:  A Weinstein; O Brickner; H Lerman; M Greemland; M Bloch; H Lester; R Chisin; Y Sarne; R Mechoulam; R Bar-Hamburger; N Freedman; E Even-Sapir
Journal:  J Psychopharmacol       Date:  2008-06       Impact factor: 4.153

8.  Reversal of age-related cognitive impairments in mice by an extremely low dose of tetrahydrocannabinol.

Authors:  Yosef Sarne; Roni Toledano; Lital Rachmany; Effrat Sasson; Ravid Doron
Journal:  Neurobiol Aging       Date:  2017-10-06       Impact factor: 4.673

9.  Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.

Authors:  Charlotte Marie Pretzsch; Jan Freyberg; Bogdan Voinescu; David Lythgoe; Jamie Horder; Maria Andreina Mendez; Robert Wichers; Laura Ajram; Glynis Ivin; Martin Heasman; Richard A E Edden; Steven Williams; Declan G M Murphy; Eileen Daly; Gráinne M McAlonan
Journal:  Neuropsychopharmacology       Date:  2019-02-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.